Publication: The second mini-transplant for unstable mixed chimerism within the first 100 days after hematopoietic stem cell transplant in severe thalassemia
Issued Date
2012-09-01
Resource Type
ISSN
13993046
13973142
13973142
Other identifier(s)
2-s2.0-84864621281
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Pediatric Transplantation. Vol.16, No.6 (2012)
Suggested Citation
Worawut Choeyprasert, Samart Pakakasama, Usanarat Anurathapan, Duantida Songdej, Nongnuch Sirachainun, Somtawin Sirireung, Wanpen Panthangkool, Suradej Hongeng The second mini-transplant for unstable mixed chimerism within the first 100 days after hematopoietic stem cell transplant in severe thalassemia. Pediatric Transplantation. Vol.16, No.6 (2012). doi:10.1111/j.1399-3046.2011.01577.x Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/14651
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
The second mini-transplant for unstable mixed chimerism within the first 100 days after hematopoietic stem cell transplant in severe thalassemia
Other Contributor(s)
Abstract
Allogeneic HSCT is the only curative treatment for severe thalassemia disease. MC occurs in one-third of these patients within the first two months after HSCT; this is a major risk factor of graft rejection, especially when RHCs are more than 25%. There is still no consensus for the management of MC, especially in the early phase of HSCT. The DLI has also been described in the treatment of MC following HSCT for hemoglobinopathies, but its success is still not guaranteed. The second HSCT has been an approach used in an attempt to cure patients who reject their graft. Concern about toxicity of conditioning regimen, the second HSCT is usually delayed for at least a year after the first HSCT. We would like to demonstrate the successful use of the second mini-allogeneic HSCT in hemoglobin E/β-thalassemia with evidence of unstable MC in the first 100 days after allogeneic HSCT to prevent further graft loss after allogeneic HSCT. © 2011 John Wiley & Sons A/S.